Testing effectiveness (Phase 2)UnknownNCT04622865
What this trial is testing
Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19
Who this might be right for
SARS-CoV 2COVID-19Coronavirus Disease 2019
AB Science 200